We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
3-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
3-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average FPKM
840.2
Number of samples
102
Samples
Sample
Description
FPKM
TCGA-ER-A196-01A
64 years, female, white, stage:iic, alive, 1785 days
2607.8
TCGA-IH-A3EA-01A
61 years, male, white, stage:iic, alive, 524 days
2351.0
TCGA-BF-A1Q0-01A
80 years, male, white, stage:iic, alive, 831 days
2174.6
TCGA-GF-A769-01A
39 years, male, white, stage:iic, dead, 1070 days
2042.3
TCGA-GN-A26C-01A
77 years, male, white, stage:iiic, dead, 821 days
1874.5
TCGA-GN-A263-01A
24 years, male, white, stage:iv, dead, 467 days
1866.0
TCGA-EB-A85J-01A
66 years, female, white, stage:iib, alive, 360 days
1814.1
TCGA-BF-A1PV-01A
74 years, female, white, stage:iic, alive, 14 days
1808.1
TCGA-EB-A3XE-01A
77 years, female, white, stage:iia, alive, 180 days
1732.7
TCGA-EB-A41A-01A
90 years, male, white, stage:iic, alive, 262 days
1679.0
TCGA-EB-A82B-01A
58 years, female, asian, stage:iii, alive, 390 days
1646.5
TCGA-EB-A4P0-01A
82 years, male, white, stage:iic, dead, 326 days
1498.5
TCGA-YG-AA3N-01A
67 years, male, stage:iic, alive, 306 days
1493.0
TCGA-BF-AAOX-01A
83 years, male, white, stage:iic, alive, 444 days
1469.0
TCGA-EB-A5UM-01A
48 years, female, white, stage:iic, alive, 779 days
1424.3
TCGA-EB-A51B-01A
53 years, male, white, stage:iic, alive, 931 days
1345.4
TCGA-ER-A19K-01A
79 years, female, white, stage:iic, dead, 469 days
1340.2
TCGA-BF-AAOU-01A
73 years, female, white, stage:iic, alive, 476 days
1323.7
TCGA-BF-A1PZ-01A
71 years, female, white, stage:iib, alive, 853 days
1308.6
TCGA-XV-A9W5-01A
51 years, male, white, stage:i/ii nos, alive, 392 days
1300.3
TCGA-EB-A57M-01A
56 years, male, asian, stage:iiib, dead, 472 days
1251.8
TCGA-EB-A97M-01A
66 years, male, white, stage:iic, alive, 414 days
1251.6
TCGA-D9-A4Z5-01A
68 years, male, white, stage:iib, alive, 218 days
1236.0
TCGA-FR-A3R1-01A
69 years, male, white, stage:iic, alive, 685 days
1179.6
TCGA-EB-A3Y7-01A
86 years, female, white, stage:iiib, dead, 326 days
1155.6
TCGA-XV-AAZY-01A
76 years, female, white, stage:iiic, alive, 405 days
1100.7
TCGA-BF-A5ES-01A
76 years, female, white, stage:iic, alive, 490 days
1097.9
TCGA-ER-A194-01A
77 years, male, white, dead, 1354 days
1078.1
TCGA-ER-A2NF-01A
53 years, male, white, stage:iiib, dead, 877 days
1038.2
TCGA-BF-AAP4-01A
61 years, male, white, stage:iic, alive, 335 days
1027.8
TCGA-EB-A82C-01A
70 years, female, asian, stage:iic, alive, 17 days
984.5
TCGA-BF-A5ER-01A
63 years, male, white, stage:iic, alive, 327 days
980.2
TCGA-WE-A8K4-01A
85 years, male, white, stage:iib, alive, 614 days
970.2
TCGA-EB-A4IS-01A
77 years, male, white, stage:iib, alive, 774 days
943.8
TCGA-FR-A2OS-01A
49 years, female, white, stage:iic, dead, 368 days
938.8
TCGA-FR-A726-01A
90 years, male, white, stage:iic, dead, 305 days
925.5
TCGA-EB-A41B-01A
76 years, female, white, stage:iic, alive, 291 days
887.9
TCGA-EB-A1NK-01A
48 years, male, white, stage:iic, alive, 1039 days
851.6
TCGA-BF-A1PU-01A
46 years, female, white, stage:iic, alive, 387 days
850.1
TCGA-EB-A553-01A
62 years, male, white, stage:iic, alive, 226 days
844.2
TCGA-XV-AAZW-01A
62 years, female, white, stage:ii, dead, 393 days
829.0
TCGA-BF-A5EQ-01A
63 years, male, white, stage:iic, alive, 323 days
817.4
TCGA-EB-A4XL-01A
56 years, female, white, stage:iic, alive, 777 days
812.8
TCGA-EB-A42Z-01A
49 years, male, asian, stage:iiic, alive, 441 days
811.1
TCGA-BF-AAP2-01A
62 years, male, white, stage:iib, alive, 405 days
804.1
TCGA-EB-A42Y-01A
73 years, female, asian, stage:iic, dead, 721 days
768.7
TCGA-EB-A85I-01A
66 years, male, white, stage:iic, alive, 362 days
748.9
TCGA-BF-A3DN-01A
81 years, female, white, stage:iiic, alive, 717 days
742.2
TCGA-BF-AAP7-01A
76 years, female, white, stage:iic, alive, 318 days
704.3
TCGA-EB-A24C-01A
56 years, male, white, alive, 632 days
690.3
TCGA-EB-A3XF-01A
57 years, male, white, stage:iic, alive, 278 days
685.3
TCGA-D9-A4Z3-01A
73 years, female, white, stage:iiic, alive, 505 days
683.0
TCGA-ER-A19T-01A
51 years, male, white, stage:iv, dead, 270 days
665.4
TCGA-FS-A1ZN-01A
43 years, male, white, stage:iiia, dead, 730 days
636.1
TCGA-BF-A5EP-01A
75 years, female, white, stage:iiic, alive, 335 days
622.6
TCGA-EB-A551-01A
78 years, female, white, stage:iiic, alive, 590 days
615.0
TCGA-EB-A6QZ-01A
76 years, female, white, stage:iia, dead, 352 days
613.4
TCGA-BF-A5EO-01A
65 years, male, white, stage:iic, alive, 703 days
605.7
TCGA-EB-A5VU-01A
56 years, male, asian, stage:iiib, dead, 321 days
598.4
TCGA-XV-AAZV-01A
56 years, female, white, stage:ii, alive, 412 days
567.1
TCGA-GN-A8LN-01A
68 years, male, white, stage:iic, alive, 772 days
563.8
TCGA-EB-A4OY-01A
65 years, female, white, stage:iiib, alive, 977 days
558.4
TCGA-D9-A3Z4-01A
54 years, male, white, stage:iiic, dead, 519 days
555.9
TCGA-EB-A431-01A
34 years, male, white, stage:iic, alive, 568 days
542.1
TCGA-EB-A44P-01A
58 years, female, white, stage:iic, alive, 741 days
537.4
TCGA-EB-A4IQ-01A
42 years, female, asian, stage:iiib, dead, 636 days
535.9
TCGA-BF-A3DM-01A
63 years, male, white, stage:iia, alive, 601 days
534.4
TCGA-EB-A3HV-01A
37 years, male, white, stage:iic, alive, 39 days
520.1
TCGA-FR-A728-01A
54 years, female, white, stage:iiib, alive, 583 days
518.9
TCGA-BF-A3DL-01A
84 years, female, white, stage:iiib, alive, 769 days
518.1
TCGA-BF-A3DJ-01A
36 years, female, white, stage:iiib, alive, 464 days
514.7
TCGA-EB-A44O-01A
69 years, male, white, stage:iib, alive, 81 days
513.3
TCGA-EB-A3Y6-01A
56 years, female, white, stage:iic, alive, 126 days
510.8
TCGA-XV-A9W2-01A
81 years, male, white, stage:i, alive, 417 days
498.6
TCGA-EB-A24D-01A
72 years, male, white, stage:iiib, alive, 645 days
481.6
TCGA-GN-A4U5-01A
61 years, female, white, stage:ib, alive, 1156 days
440.7
TCGA-EB-A299-01A
63 years, male, white, stage:iia, alive, 378 days
435.1
TCGA-EB-A5SE-01A
73 years, male, white, stage:iib, dead, 401 days
426.2
TCGA-GF-A2C7-01A
48 years, male, white, stage:iic, alive, 21 days
418.3
TCGA-EB-A4OZ-01A
42 years, female, white, stage:iiic, alive, 620 days
401.2
TCGA-BF-A9VF-01A
77 years, male, white, stage:iic, alive, 440 days
392.2
TCGA-EB-A3XB-01A
63 years, male, white, stage:ii, alive, 796 days
383.1
TCGA-EB-A6R0-01A
58 years, female, white, stage:iic, dead, 608 days
380.6
TCGA-HR-A5NC-01A
90 years, female, alive, 1000 days
380.4
TCGA-BF-A1PX-01A
56 years, male, white, stage:iiib, dead, 282 days
369.6
TCGA-ER-A42H-01A
77 years, male, white, dead, 426 days
365.6
TCGA-EB-A44N-01A
59 years, male, white, stage:iic, dead, 205 days
358.8
TCGA-FW-A5DX-01A
71 years, male, white, stage:iiic, alive, 640 days
358.5
TCGA-EB-A5FP-01A
65 years, female, white, stage:iv, dead, 454 days
354.8
TCGA-EB-A3XC-01A
74 years, male, white, stage:iic, alive, 650 days
346.5
TCGA-D3-A5GT-01A
43 years, male, white, stage:iiic, alive, 487 days
345.1
TCGA-EB-A3XD-01A
53 years, female, white, stage:iic, alive, 1160 days
341.3
TCGA-DA-A960-01A
73 years, male, white, stage:iib, alive, 804 days
339.8
TCGA-BF-AAP6-01A
55 years, male, white, stage:iii, alive, 325 days
337.7
TCGA-BF-AAP8-01A
58 years, male, white, stage:iic, alive, 447 days
311.4
TCGA-D9-A4Z2-01A
50 years, male, white, stage:iiic, dead, 190 days
295.2
TCGA-ER-A2NB-01A
57 years, male, white, stage:iiib, dead, 857 days
285.3
TCGA-EB-A550-01A
75 years, female, white, stage:iic, dead, 264 days
251.8
TCGA-BF-AAP1-01A
86 years, male, white, stage:iic, alive, 409 days
246.7
TCGA-EB-A6QY-01A
71 years, male, white, stage:iic, alive, 382 days
193.7
TCGA-EB-A5SF-01A
78 years, female, white, stage:iic, dead, 369 days
177.6
TCGA-XV-A9VZ-01A
90 years, female, white, stage:ii, alive, 11 days
151.0
Show allShow less
MELANOMA - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.